A phase III, randomized study of the investigational agent TAK-700 plus prednisone for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Saad, F.; Akaza, H.; Eisenberger, M. A.; Nelson, J.; Scher, H. I.; Suzuki, K.; Wirth, M.; Webb, I. J.; Wang, J.; MacLean, D.; De Wit, R. |
| Abstract Title: | A phase III, randomized study of the investigational agent TAK-700 plus prednisone for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880304609 |
| DOI: | 10.1200/jco.2011.29.15_suppl.tps184 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS184 -- Source: Wos |
